157 related articles for article (PubMed ID: 12647510)
21. Ephedra in perspective--a current review.
Abourashed EA; El-Alfy AT; Khan IA; Walker L
Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
[TBL] [Abstract][Full Text] [Related]
22. FDA issues alert on ephedra supplements in the USA.
Nelson R
Lancet; 2004 Jan; 363(9403):135. PubMed ID: 14733193
[No Abstract] [Full Text] [Related]
23. Cardiomyopathy associated with ephedra-containing nutritional supplements.
Singh A; Rajeev AG; Dohrmann ML
Congest Heart Fail; 2008; 14(2):89-90. PubMed ID: 18401217
[No Abstract] [Full Text] [Related]
24. Ephedra: heart dangers in disguise.
Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
[No Abstract] [Full Text] [Related]
25. Cardiovascular effects of ephedra alkaloids: a comprehensive review.
Andraws R; Chawla P; Brown DL
Prog Cardiovasc Dis; 2005; 47(4):217-25. PubMed ID: 15991150
[TBL] [Abstract][Full Text] [Related]
26. Working to get ephedra banned.
Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
[No Abstract] [Full Text] [Related]
27. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.
Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
J Pain Palliat Care Pharmacother; 2004; 18(3):95-107. PubMed ID: 15364637
[TBL] [Abstract][Full Text] [Related]
28. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ; Clauson KA
J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
[TBL] [Abstract][Full Text] [Related]
29. Safety of ephedra: lessons learned.
Soni MG; Carabin IG; Griffiths JC; Burdock GA
Toxicol Lett; 2004 Apr; 150(1):97-110. PubMed ID: 15068827
[TBL] [Abstract][Full Text] [Related]
30. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
Haller CA; Benowitz NL
N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
[TBL] [Abstract][Full Text] [Related]
31. The trouble with fat-burner pills.
Smith IK
Time; 2001 Aug; 158(8):66. PubMed ID: 11534484
[No Abstract] [Full Text] [Related]
32. Myths and facts...about ephedrine use.
Munson BL
Nursing; 2003 Apr; 33(4):81. PubMed ID: 12722724
[No Abstract] [Full Text] [Related]
33. Ephedrine Alkaloids-Free Ephedra Herb Extract, EFE, Has No Adverse Effects Such as Excitation, Insomnia, and Arrhythmias.
Takemoto H; Takahashi J; Hyuga S; Odaguchi H; Uchiyama N; Maruyama T; Yamashita T; Hyuga M; Oshima N; Amakura Y; Hakamatsuka T; Goda Y; Hanawa T; Kobayashi Y
Biol Pharm Bull; 2018; 41(2):247-253. PubMed ID: 29386484
[TBL] [Abstract][Full Text] [Related]
34. Online Marketing of
Lai S; Yu C; Dennehy CE; Tsourounis C; Lee KP
J Altern Complement Med; 2021 Sep; 27(9):796-802. PubMed ID: 33979529
[No Abstract] [Full Text] [Related]
35. HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
[No Abstract] [Full Text] [Related]
36. FDA to ban sales of dietary supplements containing ephedra.
Ling AM
J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
[No Abstract] [Full Text] [Related]
37. Ephedra-free is not danger-free.
Marcus DM; Grollman AP
Science; 2003 Sep; 301(5640):1669-71; author reply 1669-71. PubMed ID: 14500960
[No Abstract] [Full Text] [Related]
38. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers.
Gardner SF; Franks AM; Gurley BJ; Haller CA; Singh BK; Mehta JL
Am J Cardiol; 2003 Jun; 91(12):1510-3, A9. PubMed ID: 12804749
[No Abstract] [Full Text] [Related]
39. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
Sharpe PA; Granner ML; Conway JM; Ainsworth BE; Dobre M
J Am Diet Assoc; 2006 Dec; 106(12):2045-51. PubMed ID: 17126636
[TBL] [Abstract][Full Text] [Related]
40. Ephedra/ephedrine: cardiovascular and CNS effects.
Wooltorton E; Sibbald B
CMAJ; 2002 Mar; 166(5):633. PubMed ID: 11898947
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
